Roger B Cohen, MD

Medical Oncology

Acting Chairman, Department of Medical Oncology

Director, Phase I Clinical Trials Program

Meet the other members of the lung cancer treatment team.

Meet the other members of the breast cancer treatment team.

Meet the other members of the head and neck cancer treatment team.

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111-2497

To make an appointment, call:
215-728-2570.

For general information, call:
1-888-FOX CHASE.
An oncology certified nurse will assist you.

Clinical Expertise:

Lung Cancer, Head and Neck Cancers, Breast Cancer, Phase I Trials

Medical Education:

Harvard Medical School, 1980, Boston, Mass.

Residency:

Internal Medicine, Mount Sinai Hospital, New York, NY

Fellowships:

Hematology, Mount Sinai Hospital;
Medical Oncology, National Cancer Institute, Bethesda, Md.

Certifications:

American Board of Internal Medicine;
Hematology;
Medical Oncology

Professional Societies:

American Society of Clinical Oncology;
American Association for Cancer Research;
American Society of Hematology

Scientific Report:

Phase I Clinical Trials Program
(This link requires Adobe® Acrobat Reader to view.)

Research Interests:

Developmental Therapeutics;
Clinical Trial Design and Analysis;
Monoclonal Antibody Therapeutics

Philadelphia Magazine
Top Doctors 2008
Medical Oncology

I am a medical oncologist with expertise in the development and use of novel cancer treatments for a variety of cancers. I see patients with a variety of cancers, including lung, head and neck, breast, and thyroid cancer as well as cancers of unknown primary site.

My research focuses on clinical trials of new anticancer treatments, including medicines and combinations of medicines being given to patients for the first time. In the course of this research, I am working on new treatment options that I hope will prove effective and eventually become available to patients with cancer everywhere.

I came to Fox Chase in 2001 because it is a unique and productive community of physicians and laboratory scientists who are focused on and committed to working together to improve cancer treatment.